“…While some studies suggest that APP plays a protective role post-TBI (Thornton, Vink, Blumbergs, & VanDen Heuvel, 2006), individuals with APOE ε4 + genotype experience increased post-injury Aβ deposition and reduced Aβ clearance (Hartman et al, 2002), which may in turn lead to an increased risk of Aβ plaque formation characteristic of dementia pathology. Compared to APOE ε3, the APOE ε4 isoform of the apolipoprotein E is also less able to repair synapses and protect neurons in the event of injury (Zhong, Scearce-Levie, Ramaswamy, & Weisgraber, 2008) (Katzman et al, 1996;Rohling et al, 2011;Sundstrom et al, 2007;Tang et al, 1996). The majority of these studies have included participants carrying the ε2 allele within the reference group despite evidence that ε2 may protect against degenerative neuropathology (Liu et al, 2013).…”